Pharmacy Quality Alliance, AllazoHealth partner to study, improve medication adherence metrics

NEW YORK — Pharmacy Quality Alliance and AllazoHealth announced the formation of a formal research partnership to study and improve medication adherence metrics.

"Through this partnership, Allazo's research will help determine ways to expand the settings of clinical care for use of PQA's medication adherence metrics,” said Woody Eisenberg, SVP performance measurement and strategic alliances for PQA. “One objective of this research will be to identify ways in which the adherence metrics can be harmonized with other existing metrics used within accountable care models that can lead to measureable improvements in clinical outcomes."

AllazoHealth is a predictive analytics firm that specializes in predicting patients' adherence to medications, how to best influence them to take their medication, and determining the impact of improving medication adherence on future healthcare costs and clinical outcomes. Another important objective of the research partnership is to assess the clinical and financial impact of increasing patients' medication adherence across a range of clinical settings, including Accountable Care Organizations.

"PQA is an extremely important standard setting body for medication adherence," said AllazoHealth CEO, Clifford Jones. “We are happy to be working directly with PQA to improve the way medication adherence is measured."